SANAREGEN
Live / Applied — Response to non-final action entered (as of 14 Oct 2025)
What this means for you
Not registered yet, but its 28 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98823482
- Mark type
- Stylized text
- Filed
- 28 Oct 2024
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Sanaregen Vision Therapeutics, LLC, West Miami, FL, US
Prosecution history
- 14 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 May 2025 — NON-FINAL ACTION E-MAILED
- 23 May 2025 — NON-FINAL ACTION WRITTEN
- 29 Apr 2025 — ASSIGNED TO EXAMINER
- 24 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2024 — APPLICATION FILING RECEIPT MAILED
- 28 Oct 2024 — NEW APPLICATION ENTERED